LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION

April 28, 2023

TO:	Honorable Stephanie Klick, Chair, House Committee on Public Health
FROM:	Jerry McGinty, Director, Legislative Budget Board
IN RE:	HB1190 by Klick (relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.), Committee Report 1st House, Substituted

No significant fiscal implication to the State is anticipated.

Based on the information provided by the Texas Medical Board, the Health and Human Services Commission, the Board of Pharmacy, and the Department of State Health Services, duties and responsibilities associated with implementing the bill's provisions could be accomplished by utilizing existing resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies:

503 Texas Medical Board, 507 Texas Board of Nursing, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of

LBB Staff:

JMc, NPe, BFa